Company / Inventory
Edwards Lifesciences Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$1.1B
FY2025
5-year range
$726.7M / $1.2B
FY2021-FY2025
Trend
+3.6%
vs FY2024
Sector context
#20 of 115
Health Care
What the data says
Edwards Lifesciences's inventory of $1.1B is higher than 83% of companies in the Health Care sector (FY2025). Inventory has fluctuated over the past 10 years, ranging from $397M in FY2016 to $1.2B in FY2023.
Based on SEC 10-K filings.
$1.1B in FY2025 with a 5-year CAGR of +7.0%. Top quartile in the Health Care sector.
Declined from $1.2B to $1.1B over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +8.8%
- 5-Year CAGR
- +7.0%
- 10-Year CAGR
- -
Sector benchmark
Top 17% in Health CareTop 17% of 115This company $1.1B Sector average $1.4B
▼
-19.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +7.0%, indicating consistent growth.
- In FY2025, inventory increased 3.6% year-over-year.
- Ranks #20 out of 115 companies in the Health Care sector.
- Peak inventory was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 3.16 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.1B | +3.6% |
| FY2024 | $1.1B | -7.0% |
| FY2023 | $1.2B | +33.4% |
| FY2022 | $875.5M | +20.5% |
| FY2021 | $726.7M | -9.4% |
| FY2020 | $802.3M | +25.2% |
| FY2019 | $640.9M | +5.6% |
| FY2018 | $607.0M | +9.4% |
| FY2017 | $554.9M | +39.9% |
| FY2016 | $396.6M | +16.7% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026